Bright Minds Biosciences Inc (NASDAQ:DRUG) shares are trading higher again after soaring last week. The company on Monday announced a new collaboration with brain health-focused AI company Firefly Neuroscience. What Happened: Bright Minds announced that it’s collaborating with Firefly Neuroscience to provide a full analysis of the electroencephalogram (EEG) data in the company’s BREAKTHROUGH study. BREAKTHROUGH is an open-label Phase 2 clinical trial evaluating the safety, tolerability and efficacy of BMB-101 in adult patients with classic Absence Epilepsy and Developmental Epileptic Encephalo…